Clinical trial
Pirfenidone: A New Drug to Treat Kidney Disease in Patients With Diabetes
NCT00063583 · Sharma, Kumar, M.D., Other · Completed
Key facts
| NCT number | NCT00063583 |
|---|---|
| Title | Pirfenidone: A New Drug to Treat Kidney Disease in Patients With Diabetes |
| Official title | Pirfenidone: A Novel Anti-Scarring Therapy for Diabetic Nephropathy |
| Lead sponsor | Sharma, Kumar, M.D., Other |
| Collaborators | National Institutes of Health (NIH) NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Diabetic Nephropathy |
| Intervention type | Drug |
| Interventions | Pirfenidone |
| Enrollment | 77 |
| Start date | Jun 1, 2003 |
| Primary completion | Nov 1, 2007 |
| Completion | Mar 1, 2009 |
| First posted | Jul 2, 2003 |
| Last update posted | Nov 4, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: